Cwm LLC Sells 16,062 Shares of Healthpeak Properties, Inc. $DOC

Cwm LLC decreased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 34.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,822 shares of the real estate investment trust’s stock after selling 16,062 shares during the period. Cwm LLC’s holdings in Healthpeak Properties were worth $540,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in DOC. Brooklyn Investment Group grew its position in Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 873 shares in the last quarter. TCTC Holdings LLC grew its position in Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 751 shares in the last quarter. Dagco Inc. bought a new position in Healthpeak Properties in the first quarter valued at $30,000. GKV Capital Management Co. Inc. bought a new position in Healthpeak Properties in the first quarter valued at $36,000. Finally, Larson Financial Group LLC grew its position in Healthpeak Properties by 120.6% in the first quarter. Larson Financial Group LLC now owns 1,873 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 1,024 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker acquired 1,490 shares of the company’s stock in a transaction on Monday, August 4th. The stock was acquired at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the purchase, the chief executive officer directly owned 211,906 shares of the company’s stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last ninety days, insiders have bought 8,783 shares of company stock valued at $150,129. 0.23% of the stock is owned by insiders.

Healthpeak Properties Stock Performance

NYSE DOC opened at $18.75 on Friday. The firm has a 50-day moving average of $18.32 and a 200-day moving average of $17.91. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The stock has a market cap of $13.03 billion, a PE ratio of -374.95, a P/E/G ratio of 3.16 and a beta of 1.09. Healthpeak Properties, Inc. has a 52-week low of $16.63 and a 52-week high of $23.12.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.43%. The company had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter last year, the company posted $0.45 EPS. Healthpeak Properties’s quarterly revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be paid a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.5%. Healthpeak Properties’s payout ratio is 508.33%.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of analyst reports. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Monday, September 15th. Scotiabank downgraded shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and decreased their target price for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Evercore ISI set a $22.00 target price on shares of Healthpeak Properties in a research report on Monday, September 15th. Morgan Stanley decreased their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday, August 22nd. Finally, Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the company an “outperform” rating in a research note on Wednesday, July 30th. Eight investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $21.33.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.